Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis

Colorectal cancer is one common digestive malignancy, and the most common approach of blood metastasis of colorectal cancer is through the portal vein system to the liver. Early detection and treatment of liver metastasis is the key to improving the prognosis of the patients. Radiomics and radiogeno...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2022-01, Vol.11, p.689509-689509
Main Authors: Wang, Yun, Ma, Lu-Yao, Yin, Xiao-Ping, Gao, Bu-Lang
Format: Article
Language:English
Subjects:
colorectal cancer
gene
liver metastasis
Oncology
prognosis
radiomics
treatment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Colorectal cancer is one common digestive malignancy, and the most common approach of blood metastasis of colorectal cancer is through the portal vein system to the liver. Early detection and treatment of liver metastasis is the key to improving the prognosis of the patients. Radiomics and radiogenomics use non-invasive methods to evaluate the biological properties of tumors by deeply mining the texture features of images and quantifying the heterogeneity of metastatic tumors. Radiomics and radiogenomics have been applied widely in the detection, treatment, and prognostic evaluation of colorectal cancer liver metastases. Based on the imaging features of the liver, this paper reviews the current application of radiomics and radiogenomics in the diagnosis, treatment, monitor of disease progression, and prognosis of patients with colorectal cancer liver metastases.
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2021.689509